
FDA’s CDER Uses Drug Alerts to Flag Fast-Moving Safety Issues
The FDA’s Center for Drug Evaluation and Research is using public Drug Alerts and Statements to quickly flag emerging medicine safety concerns.
Clear reporting on the stories that matter.
Articles currently tagged Public Health.

The FDA’s Center for Drug Evaluation and Research is using public Drug Alerts and Statements to quickly flag emerging medicine safety concerns.

A California jury awards $12.9m to Maria Avila, a housekeeper mauled in 2020 by a guard dog at Chris Brown’s Tarzana home.

The FDA has posted its Novel Drug Approvals for 2025. Here’s what that early list can — and cannot — tell patients, clinicians, and investors right now.

The Texas Tech quarterback’s gambling case highlights how easy online betting is colliding with a growing addiction risk for young men.

A four‑week whole‑foods challenge in India shows how small, deliberate changes to daily eating can collide with culture, cost and habit.

A new Quentin Blake centre in London highlights how illustrators use silliness, rhythm and character design to teach children how stories work.

The World Health Organization has triggered its highest alarm level for a new Ebola outbreak, elevating the crisis onto the global health agenda.

The FDA has outlined its novel drug approvals for 2025. Here’s what that means for patients, how the process works, and why confirmation timing is hard to predict.

The FDA’s Center for Drug Evaluation and Research uses formal alerts and statements to warn about medicine risks and share safety updates with the public.

Medicare Advantage insurers are pulling out of unprofitable areas, forcing older adults to scramble for new coverage. Here’s what that means and what comes next.

Medicare Advantage insurers are pulling out of unprofitable areas, forcing older Americans to scramble for new coverage options.